Skip to main content
Veterinary Medicines

MASTI Veyxym

Authorised
  • ALPHATOCOPHEROL ACETATE
  • Retinol palmitate
  • Trypsin
  • Chymotrypsin
  • Papain

Product identification

Medicine name:
МАСТИ Вейксим
MASTI Veyxym
Active substance:
  • ALPHATOCOPHEROL ACETATE
  • Retinol palmitate
  • Trypsin
  • Chymotrypsin
  • Papain
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • ALPHATOCOPHEROL ACETATE
    120.00
    milligram(s)
    /
    10.00
    gram(s)
  • Retinol palmitate
    100000.00
    international unit(s)
    /
    10.00
    gram(s)
  • Trypsin
    240.00
    FIP
    /
    10.00
    gram(s)
  • Chymotrypsin
    2400.00
    FIP
    /
    10.00
    gram(s)
  • Papain
    6.00
    FIP
    /
    10.00
    gram(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Milk
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG52X
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Available in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1829-17.07.2012
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 22/03/2023

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 22/03/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."